المؤلفون: Kandzari DE; Piedmont Heart Institute, Atlanta, Georgia., Karmpaliotis D; Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York., Kini AS; Mount Sinai Medical Center, New York, New York., Moses JW; Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York., Tummala PE; The Heart Center of Northeast Georgia Medical Center, Gainesville, Georgia., Grantham JA; St. Luke's Mid-America Heart Institute, Kansas City, Missouri., Orr C; St. Vincent's Heart Center, Indianapolis, Indiana., Lombardi W; PeaceHealth St. Joseph Medical Center, Cardiovascular Center, North Cascade Cardiology, Bellingham, WA., Nicholson WJ; York Hospital, York, Pennsylvania., Lembo NJ; Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York., Popma JJ; Beth Israel Deaconess Medical Center, Boston, Massachusetts., Wang J; Abbott Vascular, Inc., Santa Clara, California., Zhao W; Abbott Vascular, Inc., Santa Clara, California., McGreevy R; Piedmont Heart Institute, Atlanta, Georgia.

المصدر: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions [Catheter Cardiovasc Interv] 2019 Oct 01; Vol. 94 (4), pp. 509-515. Date of Electronic Publication: 2019 Aug 24.

نوع المنشور: Clinical Trial; Journal Article; Multicenter Study

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 100884139 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1522-726X (Electronic) Linking ISSN: 15221946 NLM ISO Abbreviation: Catheter Cardiovasc Interv Subsets: MEDLINE

مواضيع طبية MeSH: Drug-Eluting Stents*, Cardiovascular Agents/*administration & dosage , Coronary Occlusion/*therapy , Everolimus/*administration & dosage , Percutaneous Coronary Intervention/*instrumentation, Aged ; Cardiovascular Agents/adverse effects ; Chronic Disease ; Coronary Occlusion/diagnostic imaging ; Coronary Occlusion/mortality ; Coronary Occlusion/physiopathology ; Coronary Thrombosis/etiology ; Coronary Thrombosis/mortality ; Everolimus/adverse effects ; Female ; Humans ; Male ; Middle Aged ; Myocardial Infarction/etiology ; Myocardial Infarction/mortality ; Percutaneous Coronary Intervention/adverse effects ; Percutaneous Coronary Intervention/mortality ; Prospective Studies ; Prosthesis Design ; Risk Factors ; Time Factors ; Treatment Outcome ; United States ; Vascular Patency

المؤلفون: Gul B; Division of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut., Kozuma K; Division of Cardiovascular Medicine, Teikyo University, Tokyo, Japan., Haimi I; Division of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut., Zhao W; Abbott Vascular, Santa Clara, California., Simonton C; Abbott Vascular, Santa Clara, California., Ying SW; Abbott Vascular, Santa Clara, California., Buda A; Division of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut., Mehta S; Lumen Global and LATIN, Miami, Florida., Baumbach A; Division of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.; Department of Cardiology, St Bartholomew's Hospital, London, United Kingdom.; William Harvey Research Institute and Queen Mary University of London, London, United Kingdom., Lansky A; Division of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.; Department of Cardiology, St Bartholomew's Hospital, London, United Kingdom.; William Harvey Research Institute and Queen Mary University of London, London, United Kingdom.

المصدر: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions [Catheter Cardiovasc Interv] 2018 Nov 01; Vol. 92 (5), pp. E341-E347. Date of Electronic Publication: 2018 May 10.

نوع المنشور: Comparative Study; Journal Article; Multicenter Study

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 100884139 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1522-726X (Electronic) Linking ISSN: 15221946 NLM ISO Abbreviation: Catheter Cardiovasc Interv Subsets: MEDLINE

مواضيع طبية MeSH: Healthcare Disparities* , Percutaneous Coronary Intervention*/adverse effects , Percutaneous Coronary Intervention*/instrumentation , Percutaneous Coronary Intervention*/mortality, Non-ST Elevated Myocardial Infarction/*therapy , ST Elevation Myocardial Infarction/*therapy, Aged ; China ; Clinical Trials as Topic ; Female ; Hemorrhage/mortality ; Humans ; Japan ; Male ; Middle Aged ; Non-ST Elevated Myocardial Infarction/diagnostic imaging ; Non-ST Elevated Myocardial Infarction/mortality ; Product Surveillance, Postmarketing ; Registries ; Retrospective Studies ; Risk Assessment ; Risk Factors ; ST Elevation Myocardial Infarction/diagnostic imaging ; ST Elevation Myocardial Infarction/mortality ; Sex Factors ; Stents ; Time Factors ; Treatment Outcome ; United States

المؤلفون: Hermiller JB; Division of Cardiology, St. Vincent Heart Center of Indiana, Indianapolis, Indiana., Rutledge DR, Mao VW, Zhao W, Wang J, Gruberg L, Lombardi W, Sharma SK, Krucoff MW

المصدر: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions [Catheter Cardiovasc Interv] 2014 Jul 01; Vol. 84 (1), pp. 7-16. Date of Electronic Publication: 2014 Jan 13.

نوع المنشور: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 100884139 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1522-726X (Electronic) Linking ISSN: 15221946 NLM ISO Abbreviation: Catheter Cardiovasc Interv Subsets: MEDLINE

مواضيع طبية MeSH: Drug-Eluting Stents*, Coronary Artery Disease/*surgery , Coronary Vessels/*surgery , Myocardial Revascularization/*methods , Product Surveillance, Postmarketing/*methods , Sirolimus/*analogs & derivatives, Coronary Angiography ; Coronary Artery Disease/diagnostic imaging ; Everolimus ; Female ; Follow-Up Studies ; Humans ; Immunosuppressive Agents/pharmacology ; Male ; Middle Aged ; Prospective Studies ; Prosthesis Design ; Sirolimus/pharmacology ; Treatment Outcome

المؤلفون: Sudhir K; Center for Cardiovascular Technology, Stanford University, Palo Alto, California; Abbott Vascular, Santa Clara, California., Hermiller JB, Naidu SS, Henry TD, Mao VW, Zhao W, Ferguson JM, Wang J, Jonnavithula L, Simonton CA, Rutledge DR, Krucoff MW

مؤلفون مشاركون: XIENCE V USA Investigators

المصدر: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions [Catheter Cardiovasc Interv] 2013 Oct 01; Vol. 82 (4), pp. E385-94. Date of Electronic Publication: 2013 Mar 28.

نوع المنشور: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 100884139 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1522-726X (Electronic) Linking ISSN: 15221946 NLM ISO Abbreviation: Catheter Cardiovasc Interv Subsets: MEDLINE

مواضيع طبية MeSH: Drug-Eluting Stents*, Cardiovascular Agents/*administration & dosage , Myocardial Infarction/*therapy , Percutaneous Coronary Intervention/*instrumentation , Sirolimus/*analogs & derivatives, Aged ; Coronary Thrombosis/etiology ; Everolimus ; Female ; Humans ; Male ; Middle Aged ; Myocardial Infarction/diagnosis ; Myocardial Infarction/mortality ; Percutaneous Coronary Intervention/adverse effects ; Percutaneous Coronary Intervention/mortality ; Product Surveillance, Postmarketing ; Prospective Studies ; Risk Factors ; Sirolimus/administration & dosage ; Time Factors ; Treatment Outcome ; United States